hims glp 1 & Hers announces access to compounded GLP-1 injections for as low as $99/month to U.S. military, veterans, teachers, nurses and first responders Get after your goal weight

R., Kanoski, S

94% reduction in progression from pre diabetes to type 2 diabetes with tirzepatide.** **Based on a three-year clinical trial study (176-week treatment period) sponsored by Eli Lilly and Company, weekly injections of tirzepatide significantly reduced the risk of progression to type 2 diabetes by 94% in adults with prediabetes who were overweight or obese compared to placebo

J., Li, Y

Patients with Cardiovascular Risk Factors: Research suggests that GLP1 receptor agonists may provide cardiovascular benefits, including reduced risk of heart attack and stroke in patients with type 2 diabetes

By stabilising blood glucose within target ranges, GLP-1 receptor agonists may alleviate these symptoms, leading to a subjective sense of having more energy throughout the day